News
Filters
Showing 1 - 10 out of 40 results
Article
KCTV: Saint Luke’s Patient Avoids Third Open Heart Surgery Thanks to Minimally Invasive Procedure
Born with congenital heart disease, 41-year-old Christin Murphy has undergone three heart surgeries to repair pulmonary valves. They have been tough to get through, but Murphy says this latest one at Saint Luke’s changed her outlook.
Patient Stories
A Heart Care Experience to Remember: For a Kansas Citian With a History of Heart Issues, the Proactive, Personable Care at Saint Luke’s Stood Out
Born with congenital heart disease, Christin Murphy, 41, was familiar with cardiology appointments, stress tests, and surgeries.
Patient Stories
"Grateful and Humbled": The Back-to-Back Transplants at Saint Luke's that Saved One Man's Life
Anthony Weatherspoon, 68, of Lee’s Summit, Missouri, remembers it like it was yesterday: The day he wasn’t feeling very well in 2024. “I didn’t know what was up,” Anthony says, with his wife, Peggy, at his side.
News
KSHB: Oklahoma Family Travels to Kansas City to Receive Lifesaving Heart Procedure
Chandler DeBolt needed immediate attention but had extremely limited options before his family was referred to the Adult Congenital Heart Disease program at Saint Luke’s Mid America Heart Institute in Kansas City.
News
BBC News: Studies Reveal New Effects of Semaglutide
BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.
Article
American Journal of Managed Care: Semaglutide Enhances Heart Failure Outcomes in Obesity
A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.
News
Healio: Treatment Effect of Bystander CPR Varies by Race, Sex
On average, survival benefits of CPR for cardiac arrest could be three times as high for white adults compared to Black adults and twice as high for men compared to women.
Article
Health News You Can Use: Alzheimer’s Disease Prevention and Treatment
Nearly 7 million people in the U.S. are living with Alzheimer’s disease. That number is expected to double by the year 2060.
News
Cardiovascular Business: Semaglutide Improves Heart Failure Symptoms in Both Sexes—Weight Loss Greater in Women
Semaglutide improves symptoms in both men and women who present with heart failure. When it comes to weight loss, however, the drug appears to benefit women much more than men.
Article
U.S. News & World Report: Mummies Study Finds Heart Disease Plagued the Ancients, Too
U.S. News & World Report shares results of a new study finding heart disease has plagued humanity for centuries.